Bio Medica Laboratories's total inventories for the quarter that ended in Mar. 2025 was ₹181.4 Mil. Bio Medica Laboratories's average total inventories from the quarter that ended in Mar. 2024 to the quarter that ended in Mar. 2025 was ₹127.5 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Bio Medica Laboratories's Net-Net Working Capital per share for the quarter that ended in Mar. 2025 was ₹-9.73.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Bio Medica Laboratories's Days Inventory for the
six
months ended in Mar. 2025 was 114.83.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bio Medica Laboratories's Inventory Turnover for the quarter that ended in Mar. 2025 was 1.59.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bio Medica Laboratories's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.33.
Bio Medica Laboratories (NSE:BMLL) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Bio Medica Laboratories's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2025 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bio Medica Laboratories's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Bio Medica Laboratories Total Inventories Related Terms
Bio Medica Laboratories Total Inventories Historical Data
* Premium members only.
The historical data trend for Bio Medica Laboratories's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Medica Laboratories Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Bio Medica Laboratories (NSE:BMLL) has a Total Inventories of ₹181.4 Mil as of Mar. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Bio Medica Laboratories and its competitors.
Is Bio Medica Laboratories' Total Inventories too high?
Bio Medica Laboratories' current Total Inventories is ₹181.4 Mil. Overall, Bio Medica Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' Total Inventories compare to ISRG and BDX?
Bio Medica Laboratories' Total Inventories of ₹181.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Medical Devices & Instruments company?
A good Total Inventories depends on the Medical Devices & Instruments industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Bio Medica Laboratories and its competitors. Bio Medica Laboratories's current Total Inventories is ₹181.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current Total Inventories of ₹181.4 Mil. The current Total Inventories is ₹181.4 Mil. Bio Medica Laboratories' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current Total Inventories is ₹181.4 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
14GF Score
Get the complete analysis for NSE:BMLL
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BMLL has been successfully added to your 